State AG Monitor

Tag Archives: Arkansas AG

$1.1 Billion Verdict Demonstrates Continued Allure to AGs of Drug-Marketing Lawsuits

By Bernard Nash , Divonne Smoyer , Milton A. Marquis , and Christopher J. Allen on Posted in Consumer Protection, Contingency-Fee Counsel, Healthcare, Medicaid Fraud, Pharmaceuticals

As we noted earlier this month, an Arkansas state court recently handed down a $1.1 billion judgment in a lawsuit brought by the Arkansas AG against Janssen Pharmaceuticals and its parent Johnson & Johnson after a jury found that the company had concealed the risks associated with its antipsychotic drug Risperdal. The size of the award… Continue Reading